Status:
COMPLETED
The Need for FibEr Addition in SympTomatic Heart Failure
Lead Sponsor:
University of Alberta
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
FEAST-HF is a single-centre clinical trial in ambulatory patients with chronic HF to evaluate whether dietary supplementation with acacia gum reduces HF-related biomarkers NT-proBNP and ST2 and how th...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Willing and able to provide informed consent
- Patients with established Heart Failure (as per their treating physician) including those with both reduced and preserved ejection fraction
Exclusion
- Patients requiring a special diet that would prohibit the intervention (e.g. celiac disease, irritable bowel disease)
- Patients who do not control their own meals (e.g. meals-on-wheels, long-term care)
- Patients with conditions that would interfere with the analysis of the microbiome (e.g. chronic diarrhea, recent antibiotics within the past month)
Key Trial Info
Start Date :
September 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03409926
Start Date
September 13 2018
End Date
January 10 2022
Last Update
August 18 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N 4Z6
2
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 3V9
3
Mazankowski Heart Institute
Edmonton, Alberta, Canada, T6G 2B7